SUNPHARMA had a strong weekly performance, returning 2.72% with a relatively low volatility of 12.18%. This outperformed peers DRREDDY and HINDUNILVR, but underperformed DIVISLAB. The stock's Sharpe Ratio of 1.17 indicates a favorable risk-return profile, and the Max Drawdown of 0.0% suggests minimal downside risk. Overall, SUNPHARMA demonstrated a relatively stable and profitable week.

[Volatility: 12.18%]